Gts Securities LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $1.31 Million - $1.57 Million	-83,000 Reduced 17.69%	386,300 $6.96 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $3.14 Million - $4.27 Million	-245,400 Reduced 34.34%	469,300 $7.63 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $5.04 Million - $6.81 Million	471,900 Added 194.36%	714,700 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $105,559 - $138,190	13,000 Added 5.66%	242,800 $2.53 Million
Q3 2023 Nov 15, 2023	BUY	$7.48 - $10.7 $1.72 Million - $2.46 Million	229,800 New	229,800 $2.34 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.